Loading company…
Cambridge-based bioinformatics company, now operating as Velsera, providing genomic analysis and cloud research tools.
Founded in 2009 in Cambridge, US, Seven Bridges Genomics, now operating as Velsera, provides bioinformatics solutions for genomic analysis and healthcare research. Its products include the ARIA, GRAF and RHEO platforms. The company has completed 7 deals and recently raised USD 15.00 mn in a Series C round, with a current valuation of USD 128.714 mn. William Moss is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in